Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Body Basics Inc is recalling Actra-SX 500 capsules because they contain sildenafil, an active ingredient in FDA-approved erectile dysfunction drugs, without an approved NDA or ANDA.
The Menz Club is recalling Blue Male Enhancement Pill because it contains sulfoaildenafil, an unapproved analogue of sildenafil.
Hospira is recalling 143,136 units of Lactated Ringer's and 5% Dextrose Injection due to confirmed mold contamination.
Teva Pharmaceuticals is recalling 6,692 boxes of Copaxone (glatiramer acetate) injection due to visible medical grade silicone oil in the syringes.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Precision Dose Inc. is recalling Children's Acetaminophen Oral Suspension because the label is misleading. The product contains an adult dose of acetaminophen despite the name.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl (levothyroxine sodium) tablets because they emit a strong chemical odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after opening. The recall covers 10,121 bottles distributed nationwide and in Puerto Rico.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong chemical odor after the package is opened.
Pfizer is recalling specific lots of Levoxyl tablets because they emit a strong odor after opening. Consumers should stop using the affected products.
Pfizer is recalling Levoxyl (levothyroxine sodium) tablets because they emit a strong odor after the package is opened.
Actavis South Atlantic LLC is recalling 555,672 bottles of buPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg because they failed USP dissolution test requirements.
Lupin Pharmaceuticals is recalling Suprax (cefixime) oral suspension bottles because the product may not meet color specifications after reconstitution.
GSMS Inc. is recalling specific lots of Lisinopril and Hydrochlorothiazide tablets because they contain minute stainless steel particulates.
Teva Pharmaceuticals is recalling 62,187 bottles of Cefdinir for Oral Suspension because some bottles may be improperly sealed.
Teva Pharmaceuticals is recalling Portia (levonorgestrel and ethinyl estradiol) tablets because they failed appearance specifications.
Teva Pharmaceuticals is recalling specific lots of Jolessa tablets because they failed appearance specifications. The recall is nationwide.
Dr. Reddy's is recalling specific lots of Amoxicillin for Oral Suspension because testing revealed yeast and mold growth.
Palmer Natural Products is recalling Nootropa Cognitive Enhancement Supplement because it was marketed without an approved NDA/ANDA.
West-Ward Pharmaceutical Corp. is recalling 3,061 bottles of Ethambutol Hydrochloride Tablets due to out-of-specification assay results.